Protective effects of SCOPARONE (cas 120-08-1) against lipopolysaccharide-induced acute lung injury
-
Add time:09/03/2019 Source:sciencedirect.com
The purpose of this study was to investigate the protective effects and molecular mechanisms of SCOPARONE (cas 120-08-1) on lipopolysaccharide (LPS)-induced acute lung injury in mice. Mice model of acute lung injury (ALI), induced by intranasal instillation of LPS, was used to investigate the protective effects of scoparone in vivo. The alveolar macrophages were used to investigate the molecular mechanisms of scoparone in vitro. The results showed that scoparone treatment remarkably attenuated LPS-induced pulmonary edema, histological severities, myeloperoxidase activity, and TNF-α, IL-6 and IL-1β production in vivo. We also found that scoparone inhibited LPS-induced TLR4 expression, NF-κB activation, TNF-α, IL-6 and IL-1β production in alveolar macrophages in vitro. In conclusion, our results suggest that scoparone has a protective effect on LPS-induced ALI via suppression of TLR4-mediated NF-κB signaling pathways.
We also recommend Trading Suppliers and Manufacturers of SCOPARONE (cas 120-08-1). Pls Click Website Link as below: cas 120-08-1 suppliers
Prev:SCOPARONE (cas 120-08-1) attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway
Next:Effects of SCOPARONE (cas 120-08-1) on dopamine release in PC12 cells) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Research ArticleSCOPARONE (cas 120-08-1) attenuates RANKL-induced osteoclastic differentiation through controlling reactive oxygen species production and scavenging09/06/2019
- Analytical MethodsSCOPARONE (cas 120-08-1) inhibits adipocyte differentiation through down-regulation of peroxisome proliferators-activated receptor γ in 3T3-L1 preadipocytes09/05/2019
- Effects of SCOPARONE (cas 120-08-1) on dopamine release in PC12 cells09/04/2019
- SCOPARONE (cas 120-08-1) attenuates hepatic stellate cell activation through inhibiting TGF-β/Smad signaling pathway09/02/2019
- Full length articleSCOPARONE (cas 120-08-1) attenuates high glucose-induced extracellular matrix accumulation in rat mesangial cells09/01/2019
- SCOPARONE (cas 120-08-1) prevents IL-1β-induced inflammatory response in human osteoarthritis chondrocytes through the PI3K/Akt/NF-κB pathway08/31/2019
- Original articleTherapeutic effects of SCOPARONE (cas 120-08-1) on pilocarpine (Pilo)-induced seizures in mice08/30/2019
- Full paperSCOPARONE (cas 120-08-1) attenuates angiotensin II-induced extracellular matrix remodeling in cardiac fibroblasts08/29/2019
- Structure properties of SCOPARONE (cas 120-08-1): Polymorphs and cocrystals08/28/2019